Cargando…
Sigma-1 receptor agonist fluvoxamine for postoperative delirium in older adults: report of three cases
BACKGROUND: Postoperative delirium is a topic of great importance in the geriatric surgical specialty. Although antipsychotic drugs are the medications most frequently used to treat this syndrome, these drugs are associated with a variety of adverse events, including sedation, extrapyramidal side ef...
Autores principales: | Furuse, Tsutomu, Hashimoto, Kenji |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2900235/ https://www.ncbi.nlm.nih.gov/pubmed/20573265 http://dx.doi.org/10.1186/1744-859X-9-28 |
Ejemplares similares
-
Sigma-1 receptor agonist fluvoxamine for delirium in patients with Alzheimer's disease
por: Furuse, Tsutomu, et al.
Publicado: (2010) -
Sigma-1 receptor agonist fluvoxamine for delirium in intensive care units: report of five cases
por: Furuse, Tsutomu, et al.
Publicado: (2010) -
Fluvoxamine monotherapy for psychotic depression: the potential role of sigma-1 receptors
por: Furuse, Tsutomu, et al.
Publicado: (2009) -
Fluvoxamine for aripiprazole-associated akathisia in patients with schizophrenia: a potential role of sigma-1 receptors
por: Furuse, Tsutomu, et al.
Publicado: (2010) -
Benefical Effects of Sigma-1 Agonist Fluvoxamine for Tardive Dyskinesia and Tardive Akathisia in Patients with Schizophrenia: Report of Three Cases
por: Albayrak, Yakup, et al.
Publicado: (2013)